Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.




) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 1.0%. By the end of trading, Covidien fell $0.77 (-1.3%) to $59.40 on average volume. Throughout the day, 2,059,945 shares of Covidien exchanged hands as compared to its average daily volume of 2,526,000 shares. The stock ranged in price between $59.17-$60.33 after having opened the day at $60.20 as compared to the previous trading day's close of $60.17. Other companies within the Health Services industry that declined today were:

Pingtan Marine Enterprise



), down 12.4%,

Thermogenesis Corporation



), down 11.7%,

USMD Holdings



Scroll to Continue

TheStreet Recommends

), down 10.4% and

Rochester Medical Corporation



), down 6.7%.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $27.5 billion and is part of the health care sector. Shares are up 3.4% year to date as of the close of trading on Thursday. Currently there are 13 analysts that rate Covidien a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates


as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front,

MGC Diagnostics



), up 15.9%,

Angeion Corporation



), up 15.9%,

ERBA Diagnostics



), up 9.0% and

Opko Health



), up 8.8%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care




STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.